학술논문
The potent small molecule integrin antagonist THR-687 is a promising next-generation therapy for retinal vascular disorders
Document Type
Article
Author
Source
In: Experimental Eye Research . (Experimental Eye Research, March 2019, 180:43-52)
Subject
Language
English
ISSN
10960007
00144835
00144835